Suivre
Kent Vrana
Kent Vrana
Professor and Chair of Pharmacology, Penn State College of Medicine
Adresse e-mail validée de psu.edu - Page d'accueil
Titre
Citée par
Citée par
Année
Twenty-five years of quantitative PCR for gene expression analysis
HD VanGuilder, KE Vrana, WM Freeman
Biotechniques 44 (5), 619-626, 2008
18202008
Quantitative RT-PCR: pitfalls and potential
WM Freeman, SJ Walker, KE Vrana
Biotechniques 26 (1), 112-125, 1999
17871999
Intricate regulation of tyrosine hydroxylase activity and gene expression
SC Kumer, KE Vrana
Journal of neurochemistry 67 (2), 443-462, 1996
9061996
Cytotoxic and genotoxic potential of dopamine
AH Stokes, TG Hastings, KE Vrana
Journal of neuroscience research 55 (6), 659-665, 1999
5941999
Parthenogenetic stem cells in nonhuman primates
JB Cibelli, KA Grant, KB Chapman, K Cunniff, T Worst, HL Green, ...
Science 295 (5556), 819-819, 2002
4852002
Adenosine cyclic 3', 5'-monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit
PF Cook, ME Neville Jr, KE Vrana, FT Hartl, R Roskoski Jr
Biochemistry 21 (23), 5794-5799, 1982
4751982
Fundamentals of DNA hybridization arrays for gene expression analysis
WM Freeman, DJ Robertson, KE Vrana
Biotechniques 29 (5), 1042-1055, 2000
2952000
Tyrosine mRNA is expressed in human substantia nigra
Y Xu, AH Stokes, WM Freeman, SC Kumer, BA Vogt, KE Vrana
Molecular Brain Research 45 (1), 159-162, 1997
2671997
Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase
Y Xu, AH Stokes, R Roskoski Jr, KE Vrana
Journal of neuroscience research 54 (5), 691-697, 1998
2611998
Nonhuman primate parthenogenetic stem cells
KE Vrana, JD Hipp, AM Goss, BA McCool, DR Riddle, SJ Walker, ...
Proceedings of the National Academy of Sciences 100 (suppl_1), 11911-11916, 2003
2602003
Manganese uptake and distribution in the central nervous system (CNS).
M Aschner, KE Vrana, W Zheng
Neurotoxicology 20 (2-3), 173-180, 1999
2361999
Mapping functional regions of transcription factor TFIIIA
KE Vrana, MEA Churchill, TD Tullius, DD Brown
Molecular and cellular biology, 1988
2211988
Circulating cytokines as biomarkers of alcohol abuse and alcoholism
RN Achur, WM Freeman, KE Vrana
Journal of Neuroimmune Pharmacology 5, 83-91, 2010
2202010
Nitration and inactivation of tyrosine hydroxylase by peroxynitrite
B Blanchard-Fillion, JM Souza, T Friel, GCT Jiang, K Vrana, V Sharov, ...
Journal of Biological Chemistry 276 (49), 46017-46023, 2001
2202001
Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals
CA Legare, WM Raup-Konsavage, KE Vrana
Pharmacology 107 (3-4), 131-149, 2022
2112022
The pharmacological case for cannabigerol
R Nachnani, WM Raup-Konsavage, KE Vrana
Journal of Pharmacology and Experimental Therapeutics 376 (2), 204-212, 2021
2102021
Complex molecular regulation of tyrosine hydroxylase
I Tekin, R Roskoski, N Carkaci-Salli, KE Vrana
Journal of neural transmission 121, 1451-1481, 2014
1552014
Persistent alterations in mesolimbic gene expression with abstinence from cocaine self-administration
WM Freeman, KM Patel, RM Brucklacher, ME Lull, M Erwin, D Morgan, ...
Neuropsychopharmacology 33 (8), 1807-1817, 2008
1482008
Chronic cocaine‐mediated changes in non‐human primate nucleus accumbens gene expression
WM Freeman, MA Nader, SH Nader, DJ Robertson, L Gioia, SM Mitchell, ...
Journal of neurochemistry 77 (2), 542-549, 2001
1442001
Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels
SL Vrana, KE Vrana, TR Koves, JE Smith, SI Dworkin
Journal of neurochemistry 61 (6), 2262-2268, 1993
1391993
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20